Company news from the 02/20/07 News Brief

Share this article:
GfK Market Measures has established a dedicated business unit and appointed senior industry expert in oncology, Bill Bowman, to lead the company's strategic efforts in this area of research. In his new role as VP of oncology at GfK Market Measures, Bowman, who has more than 15 years of oncology experience, will be responsible for developing syndicated products for oncology and serve as a key in-house resource for custom marketing research studies involving cancer therapies.
Share this article:

Email Newsletters

More in News

Doctors want to know how CMS plans to display Sunshine payment data

Doctors want to know how CMS plans to ...

Physician and industry trade groups are asking CMS to explain how context will be provided to the general public around the dollar sums drugmakers ascribe to doctors for things like ...

Pfizer Q2 sales slip, but still beat expectations

Pfizer Q2 sales slip, but still beat expectations

Patent losses and lost co-promotion agreements put a dent in sales.

Lack of marketing partner delays Afrezza launch

Lack of marketing partner delays Afrezza launch

Afrezza was heralded as one of the most innovative diabetes products of the last decade. So, why hasn't MannKind set a firm launch date for the product?